← Leaderboards
Frank J Martin
Imedd, Inc.
$19,334,495
Attributed
$19,334,495
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.8M · FY2012–21$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$19,334,495 · 9
By mechanism
R44$12,561,723 · 4
UG3$5,756,915 · 1
R43$1,015,857 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Implant”
- Myron S Cohen · Family Health International$91,263,426
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
- Janet T. Holbrook · Johns Hopkins University$44,705,350
- Keri Hammel · The Emmes Company, Llc$39,666,467
- Richard A Andersen · California Institute Of Technology$29,741,172
- Robert Jay Greenberg · Second Sight Medical Products, Inc.$28,210,284
Research focus
ImplantProceduresSuccessSubcutaneousPharmaceutical PreparationsTechnologyMaintenanceSafetyHealth Care CostsDevicesProgramsMedication ComplianceRisperidoneDosePre-ClinicalIn VitroReportingPlasmaDesignValidationRelapseDiffusionAutomobile DrivingBase
Grant awards (17)
Sustained Delivery of Tizanidine for Maintenance Treatment of Moderate to Severe Spasticity$1,280,691
R44 · FY2021 · NS · contact PI
1-Year Sustained Release Naltrexone Implant for the prevention of relapse to opioid dependence$3,184,237
UG3 · FY2020 · DA · contact PI
Risperidone Subcutaneous Implant$2,000,000
R44 · FY2020 · MH · contact PI
Risperidone Subcutaneous Implant$4,037,027
R44 · FY2019 · MH · contact PI
1-Year Sustained Release Naltrexone Implant for the prevention of relapse to opioid dependence$2,572,678
UG3 · FY2019 · DA · contact PI
Sustained 3-Month Delivery of Tizanidine for Maintenance Treatment of Moderate to Severe Spasticity$224,798
R43 · FY2019 · NS · contact PI
Sustained 3-Month Delivery of Stabilized Exenatide Through Nanopore Membranes for Type 2 Diabetes Therapy$734,407
R44 · FY2018 · DK · contact PI
Sustained 3-Month Delivery of Stabilized Exenatide Through Nanopore Membranes for Type 2 Diabetes Therapy$741,023
R44 · FY2017 · DK · contact PI
Sustained 3-Month Delivery of Olanzapine for Schizophrenia Maintenance Treatment$224,389
R43 · FY2017 · MH · contact PI
Risperidone Subcutaneous Implant$1,057,986
R44 · FY2015 · MH · contact PI
Risperidone Subcutaneous Implant$984,677
R44 · FY2014 · MH · contact PI
Sustained 3-Month Delivery of Stabilized Exenatide Through Nanopore Membranes for$222,459
R43 · FY2014 · DK · contact PI
Risperidone Subcutaneous Implant$117,395
R44 · FY2014 · MH · contact PI
Risperidone Subcutaneous Implant$849,613
R44 · FY2013 · MH · contact PI
Risperidone Subcutaneous Implant$344,211
R43 · FY2012 · MH · contact PI
IMMUNOISOLATION BIOCAPSULES FOR PANCREATIC ISLET CELLS$392,141
R44 · FY2003 · DK
IMMUNOISOLATION BIOCAPSULES FOR PANCREATIC ISLET CELLS$366,763
R44 · FY2002 · DK